Suppr超能文献

[免疫组织化学检测DNA错配修复蛋白缺陷在预测肿瘤微卫星状态中的价值]

[Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].

作者信息

Qin Yun, Liang Liping, Zheng Xingzheng, Zheng Jie, Ye Juxiang, Guo Limei, Zhao Feng, Shi Xueying

机构信息

School of Basic Medical Sciences, Peking University Health Science Center, Department of Pathology, Peking University Third Hospital, Beijing 100191, China.

Department of Pathology, the Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi 830011, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2015 Oct;44(10):704-8.

Abstract

OBJECTIVE

To evaluate the sensitivity and specificity of immunohistochemical (IHC) staining of DNA mismatch repair (MMR) protein for the screening of microsatellite instability (MSI) colorectal cancer (CRC).

METHODS

A total of 255 CRC cases were studied, including 140 cases of routine paraffin-embedded tissue samples and 115 cases constructed on tissue microarray. Expressions of 4 MMR proteins including MHL1, MSH2, MSH6 and PMS2 were investigated by IHC. Negative protein expression was defined as complete absence of nuclear staining within tumor cells in the presence of positively labeled internal non-neoplastic cells. Focal staining was defined as the presence of staining in < 5% of the tumor cells. CRCs showing negative staining for any MMR proteins were interpreted as MMR deficient tumors. PCR-genescan MSI analysis was performed in each case by a five marker panel including Bat26, Bat25, NR-21, NR-24 and MONO-27.

RESULTS

Among the 140 CRCs with routine formalin-fixed paraffin embedded tissue sections, concordance rate between IHC and PCR-genescan was 98.6% (138/140), the sensitivity and specificity of IHC in detecting MSI tumors were 94.9% (37/39) and 100.0% (101/101), respectively. The 2 disconcordant cases showed focal staining in at least one of the MMR proteins but were confirmed to be MSI-H CRCs by PCR-genescan assay. On tissue microarray, 91.3% (105/115) of the cases had informative results. The concordance rate between IHC and PCR-genescan was 100.0% (105/105). Both the specificity and sensitivity of IHC in detecting MSI tumors on available tissue microarray samples were 100.0%. Ten cases were inclusive due to the presence of negative stains of MMR proteins in both the tumor and internal control cells.

CONCLUSIONS

Detection of 4 MMR proteins expression by IHC is reliable for identifying MSI CRCs and is recommended for routine practice. Tumors with focal MMR protein staining are highly suspected for the presence of MSI-H and PCR-genescan based MSI analysis should be performed to confirm.

摘要

目的

评估DNA错配修复(MMR)蛋白免疫组化(IHC)染色对微卫星不稳定(MSI)结直肠癌(CRC)筛查的敏感性和特异性。

方法

共研究255例CRC病例,包括140例常规石蜡包埋组织样本和115例组织芯片构建病例。采用IHC检测4种MMR蛋白(包括MHL1、MSH2、MSH6和PMS2)的表达。阴性蛋白表达定义为在存在阳性标记的内部非肿瘤细胞的情况下,肿瘤细胞内完全没有核染色。局灶性染色定义为<5%的肿瘤细胞中存在染色。任何MMR蛋白染色呈阴性的CRC被解释为MMR缺陷肿瘤。对每例病例进行PCR-基因扫描MSI分析,采用包括Bat26、Bat25、NR-21、NR-24和MONO-27的五标记组。

结果

在140例常规福尔马林固定石蜡包埋组织切片的CRC中,IHC与PCR-基因扫描的符合率为98.6%(138/140),IHC检测MSI肿瘤的敏感性和特异性分别为94.9%(37/39)和100.0%(101/101)。2例不一致的病例在至少一种MMR蛋白中显示局灶性染色,但通过PCR-基因扫描检测确认为MSI-H CRC。在组织芯片上,91.3%(105/115)的病例有可提供信息的结果。IHC与PCR-基因扫描的符合率为100.0%(105/105)。在可用的组织芯片样本上,IHC检测MSI肿瘤的特异性和敏感性均为100.0%。10例因肿瘤细胞和内部对照细胞中MMR蛋白染色均为阴性而被纳入。

结论

通过IHC检测4种MMR蛋白表达对识别MSI CRC是可靠的,推荐用于常规实践。MMR蛋白局灶性染色的肿瘤高度怀疑存在MSI-H,应进行基于PCR-基因扫描的MSI分析以确诊。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验